Drug screening in urine
Material: | 10 ml urine |
Methods: |
Flüssigkeitschromatographie-Massenspektrometrie (LC-MS/MS) → LC-Tandem-Massenspektrometrie Ligandenassays → Enzym-Multiplied-Immunoassay (EMIT) Ligandenassays → Cloned Enzyme Donor Immunoassay (CEDI) | Reference range | See findings report |
Indication | Suspicion of drug abuse, intoxication, abstinence checks |
Please note | Simple drug screening (abbreviation: DRU1): Test for cannabinoids, cocaine, benzoylecgonine, amphetamines, methamphetamines, MDA, MDMA, opiates, methadone or EDDP by immunoassay.
Standard drug screening (abbreviation DRU2): Test for cannabinoids, cocaine, benzoylecgonine, amphetamines, methamphetamines, MDA, MDMA, opiates, methadone or EDDP by immunoassay as well as test for opiates, benzodiazepines via LC-MS/MS. When this test series is requested, we use a chromatographic method (LC-MS/MS) in addition to the immunological tests, especially for the differentiation of opiates (Morphine, 6-monoacetylmorphin, codeine, dihydrocodeine) and benzodiazepines (Diazepam, nordiazepam, oxazepam, bromazepam, flunitrazepam, 7-aminoflunitrazepam, lorazepam) as well as Z-substances (Zolpidem, zopiclone, zaleplon). This way you will receive knowledge about your patient’s drug consumption and concomitant consumption within the shortest amount of time and with only minimal analytical expenditure.
Drug- plus medication screening (abbreviation: DRU3): As per DRU2 with additional testing for tricyclic antidepressants and medication (approximately 4000 substances).
Opioid screening (abbreviation: OPIOIU):
Alcohol markers:
Advantages of the screening methods (DRU1, DRU2, DRU3):
Confirmation analysis for quick screening test: If desired, positive results from an immunochemical quick screening in the urine, obtained in your practice, can be confirmed from the leftover material with a chromatographic method.
Test for new psychoactive substances (NPS): It is possible to demonstrate a large number of modern designer drugs such as synthetic cannabinoids and cathinones as well as tryptamine- and piperazine derivates in the urine with classical methods such as GC-MS as well as with new analytical methods, especially LC-MS/MS and Q-TOF. The spectrum of substances covered is continuously increased. |
More Results for the letter A
- Accompanying substances (BEGL)
- accompanying alcohols
- ACE (ACE)
- Angio-1 converting enzyme
- Acetone (ACET)
- Acetyl carnitine in the urine (ACECAC)
- Acetylcholine receptor antibodies (AchR)
- AchR antibodies
- ACTH (ACTH)
- Adrenocorticotropic hormone
- Actinomycosis (KACTI)
- Actinomyces spp. I
- Adenovirus infection (ADVK)
- Adrenal cortex autoantibodies (NNR)
- Adrenalin in plasma (ADRE)
- Aeromonas spp. (KAERO)
- Aeromonas hydrophilia, Aeromonas sobria, Aeromonas caviae
- AFP (AFP)
- Alpha-fetoprotein
- AGS genotyping (CYP21)
- Mutation analysis of the 21-hydroxylase gene on suspicion of adrenogenital syndrome
- Albumin in CSF (ALBL)
- Albumin in the serum (ALBUM)
- Albumin in urine (ALBUC)
- Alcohol in the blood (AETHS)
- Blood alcohol
- Aldosterone in serum (ALDO)
- Aldosterone/renin quotient (ARQ)
- Alkaline leukocyte phosphatase (ALP)
- (Alkaline neutrophil phosphatase = ANP)
- Alkaline phosphatase (AP)
- Alkaline phosphatase isoenzymes (APISO)
- bone AP, liver-biliary-bowel AP
- Alkaline phosphatase of the neutrophils (ALKA01)
- Alkaline placental phosphatase (APP)
- Regan isoenzyme
- Allergen specific IgE (ALLGENSPEZ IGE)
- Allergen specific IgG with type I reaction and hyposensitization (IGG TYP I)
- Allergen specific precipitating IgG antibodies in case of exogenous allergic alveolitis (ALVEO)
- Type III allergy
- Allergy diagnostics (ALLERGIE)
- Alpha galactosidase in leucocytes (AGALA)
- Alpha-1 antitrypsin in the serum (A1A)